CHTP Key Stats
| Income Statement | |
| Revenue TTM | 0.00 |
| Revenue Quarterly YoY Growth | |
| EPS Diluted TTM | -0.3032 |
| EPS Diluted Quarterly YoY Growth | |
| Net Income TTM | -20.09M |
| Profitability | |
| Gross Profit Margin Quarterly | |
| Profit Margin Quarterly | |
| Dividend | |
| Dividend Yield | 0.00% |
| Payout Ratio TTM Pro | Go Pro |
| Current Valuation | |
| Market Cap | 126.12M |
| Enterprise Value | 101.06M |
| PE Ratio TTM | |
| PE 10 Pro | Go Pro |
| PEG Ratio | |
| Price / Book Value | 5.574 |
| Other | |
| Beta Pro | Go Pro |
| Debt to Equity Ratio | 0.00 |
| Free Cash Flow | |
| Return on Equity | -66.54% |
CHTP News
- Chelsea Therapeutics Reports First Quarter 2013 Financial Results noodls May 1
- Chelsea Therapeutics International Ltd. (CHTP) Posts Q1 Loss of 6c/Share Street Insider May 1
- CHELSEA THERAPEUTICS INTERNATIONAL, LTD. Files SEC form 10-Q, Quarterly Report May 1
- Chelsea Therapeutics to Present at the 12th Annual Needham Healthcare Conference noodls Apr 24
- Lead Counsel in Securities Class Action Against Chelsea Therapeutics Internation... Apr 19
- CHELSEA THERAPEUTICS INTERNATIONAL, LTD. Files SEC form 8-K, Change in Directors... Apr 19
- Is Chelsea Therapeutics A Buy After Skyrocketing Up Over 150%? Apr 8
- Why Starbucks is a Screaming Buy and 3 Other Hot Stocks Mar 27
- Chelsea Therapeutics (CHTP) Higher Following Blog Post Street Insider Mar 27
- Chelsea Therapeutics: A Shoe-In For FDA Approval, Shares Could Double From Here Mar 26
CHTP Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Chelsea Therapeutics International is down 5.53% over the last year vs S&P 500 Total Return up 31.68%, Achillion Pharmaceuticals up 19.54%, and Merrimack Pharmaceuticals down 24.38%.
CHTP Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Cash Flow Statement View Statement
You may also be interested in these CHTP related companies
Pro Ratings for CHTP
Pro Report PDF for CHTP
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.
Download CHTP Pro Report PDF
Pro Strategies Featuring CHTP
Did Chelsea Therapeutics International make it into our Pro Portfolio Strategies?
CHTP Profile
Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Other CHTP Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership MSN Money
- SEC Filings SEC
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| CHTP | 1.88 | -0.01 | -0.53% | 126.12M |
